|
1. |
Bioequivalence Studies for Veterinary Drug Products |
|
Clinical Research and Regulatory Affairs,
Volume 9,
Issue 1,
1992,
Page 1-9
RhodesC. T.,
Preview
|
PDF (436KB)
|
|
ISSN:1060-1333
DOI:10.3109/10601339209005324
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
2. |
An Overview of Pulmonary Complications of Aids |
|
Clinical Research and Regulatory Affairs,
Volume 9,
Issue 1,
1992,
Page 11-45
YoungRoscoe C.,
RachalRaylinda E.,
KennedyKathleen B.,
Preview
|
PDF (1311KB)
|
|
摘要:
AbstractPulmonary complications in acquired immunodeficiency syndrome (AIDS) occur because the human immunodeficiency virus (HIV) has neutralized the cellular defenses of the lung, and in part, the mechanical and inflammatory responses as well. The consequence of this unopposed invasion, is that rare malignant tumors, opportunistic infections, as well as recognized pathogens gain entry into the reluctant host, and culminate in the host's eventual destruction. An acceptable prognosis awaits development of more effective antiretroviral therapy, as well as more efficient specific therapy for MOST of the pulmonary complications.
ISSN:1060-1333
DOI:10.3109/10601339209005325
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
3. |
Legal Reform Proposals Arising from the Food and Drug Administration Generic Drug Scandal |
|
Clinical Research and Regulatory Affairs,
Volume 9,
Issue 1,
1992,
Page 47-58
SimlotRupendra,
CampbellNorman A.,
Preview
|
PDF (426KB)
|
|
摘要:
AbstractThis study was undertaken with the help of generic drug manufacturers to learn their perceived reasons for delay in Abbreviated New Drug Application (ANDA) by the Food and Drug Administration (FDA). The research resulted into proposing legal reforms in existing laws to prevent ANDA scandals in the future.
ISSN:1060-1333
DOI:10.3109/10601339209005326
出版商:Taylor&Francis
年代:1992
数据来源: Taylor
|
|